SHE:301520 - Anhui Wanbang Pharmaceutical Technology Co Ltd

Anhui Wanbang Pharmaceutical T
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2018 Q4	2019 Q4	2020 Q4	2021 Q2	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Net Margin	[friend]	[friend]	[friend]	-	38.78% -	29.37% -24.3%	35.75% 21.7%	45.52% 27.3%	37.86% -16.8%	38.28% 1.1%	36.69% -4.2%	33.36% -9.1%	31.62% -5.2%	31.34% -0.9%
Gross Margin	[friend]	[friend]	[friend]	-	52.71% -	100% 89.7%	50.08% -49.9%	53% 5.8%	50.38% -4.9%	55.59% 10.3%	51.4% -7.5%	50.83% -1.1%	48.94% -3.7%	47.67% -2.6%
Operating Margin	[friend]	[friend]	[friend]	-	41.05% -	100% 143.6%	36.83% -63.2%	51.15% 38.9%	40% -21.8%	46.3% 15.7%	40.18% -13.2%	35.72% -11.1%	32.85% -8.0%	30% -8.7%
Total Revenue	[friend]	[friend]	[friend]	-	-	-	-	72.72M -	260.78M 258.6%	291.33M 11.7%	318.13M 9.2%	321.07M 0.9%	341.81M 6.5%	359.92M 5.3%
Total Assets	[friend]	[friend]	[friend]	225.69M -	283.63M 25.7%	-	332.36M -	-	404.6M -	423.02M 4.6%	465.1M 9.9%	1.52B 226.4%	1.54B 1.7%	1.57B 1.6%
Total Liabilities	[friend]	[friend]	[friend]	35.09M -	50.75M 44.6%	-	63.65M -	-	72.98M -	423.02M 479.6%	79.66M -81.2%	84.97M 6.7%	80.58M -5.2%	75.1M -6.8%
Total Equity	[friend]	[friend]	[friend]	190.6M -	232.88M 22.2%	-	268.71M -	-	331.62M -	356.6M 7.5%	385.44M 8.1%	1.43B 271.8%	1.46B 2.1%	1.49B 2.0%
Operating CashFlow	[friend]	[friend]	[friend]	15.48M -67.1%	55.43M 258.0%	-	63.67M -	-	72.32M -	-	84.28M -	-	71.92M -	-
Beginning Cash Position	[friend]	[friend]	[friend]	119.87M 2024.2%	119.87M 0%	-	125.78M -	179.9M 43.0%	161.47M -10.2%	186.15M 15.3%	179.9M -3.4%	187M 3.9%	186.15M -0.5%	159.9M -14.1%
End Cash Position	[friend]	[friend]	[friend]	125.78M 4.9%	161.47M 28.4%	-	179.9M -	187M 3.9%	186.15M -0.5%	159.9M -14.1%	170.56M 6.7%	1.05B 516.6%	253.5M -75.9%	238.75M -5.8%
Free Cash Flow	[friend]	[friend]	[friend]	5.24M -87.0%	39.84M 659.8%	-5.95M -	51.51M -	6.18M -88.0%	21.63M 250.1%	30.64M 41.7%	-12.59M -	-21.15M -	-14.05M -	-1.76M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	39.59M -27.4%	81.87M 106.8%	-	78.11M -	-	98.73M -	-	116.73M -	-	108.09M -	-
Diluted Net Income	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	-	-	-	-	0.658 -	1.97 199.2%	2.226 13.0%	2.33 4.7%	2.138 -8.3%	2 -6.4%	1.95 -2.5%
Return On Equity (%)	[friend]	[friend]	[friend]	-	42.65% -	-	34.01% -	-	34.98% -	31.28% -10.6%	35.69% 14.1%	7.47% -79.1%	12.04% 61.1%	12.19% 1.3%
Return On Assets (%)	[friend]	[friend]	[friend]	-	33.82% -	-	27.99% -	-	28.69% -	26.36% -8.1%	29.28% 11.0%	7.06% -75.9%	11.09% 57.2%	11.33% 2.1%